These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15354980)

  • 1. Intermittent hirudin versus continuous heparin for anticoagulation in continuous renal replacement therapy.
    Hein OV; von Heymann C; Diehl T; Ziemer S; Ronco C; Morgera S; Siebert G; Kox WJ; Neumayer HH; Spies C
    Ren Fail; 2004 May; 26(3):297-303. PubMed ID: 15354980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy.
    Vargas Hein O; von Heymann C; Lipps M; Ziemer S; Ronco C; Neumayer HH; Morgera S; Welte M; Kox WJ; Spies C
    Intensive Care Med; 2001 Apr; 27(4):673-9. PubMed ID: 11403068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis.
    Fischer KG; van de Loo A; Böhler J
    Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.
    Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T
    Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
    Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
    Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study].
    Huhle G; Hoffmann U; Hoffmann I; Harenberg J; Heene DL
    Dtsch Med Wochenschr; 2000 Jun; 125(22):686-91. PubMed ID: 10874895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding after intermittent or continuous r-hirudin during CVVH.
    Kern H; Ziemer S; Kox WJ
    Intensive Care Med; 1999 Nov; 25(11):1311-4. PubMed ID: 10654220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hirudin-based anticoagulant strategy during isolated limb perfusion in a patient with heparin-induced thrombocytopenia.
    Lindemann W; Richter S; Schilling MK
    Melanoma Res; 2005 Aug; 15(4):287-90. PubMed ID: 16034307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.
    Tan HK; Baldwin I; Bellomo R
    Intensive Care Med; 2000 Nov; 26(11):1652-7. PubMed ID: 11193272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulation with hirudin for repeat cardiac surgery in a patient with heparin induced thrombocytopaenia].
    Herman K; Vaszily M; Szentgyörgyi L; Ajzner E; Muszbek L; Péterffy A
    Magy Seb; 2008; 61 Suppl():67-70. PubMed ID: 18504242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal replacement therapy and anticoagulation.
    Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II).
    Schneider T; Heuer B; Deller A; Boesken WH
    Wien Klin Wochenschr; 2000 Jun; 112(12):552-5. PubMed ID: 10953874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban for anticoagulation in continuous renal replacement therapy.
    Link A; Girndt M; Selejan S; Mathes A; Böhm M; Rensing H
    Crit Care Med; 2009 Jan; 37(1):105-10. PubMed ID: 19050602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hirudin in renal insufficiency.
    Fischer KG
    Semin Thromb Hemost; 2002 Oct; 28(5):467-82. PubMed ID: 12420243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation options for patients with heparin-induced thrombocytopenia requiring renal support in the intensive care unit.
    Davenport A
    Contrib Nephrol; 2007; 156():259-66. PubMed ID: 17464135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients.
    Koster A; Hansen R; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):243-8. PubMed ID: 10890473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iloprost for additional anticoagulation in continuous renal replacement therapy--a pilot study.
    Birnbaum J; Spies CD; Klotz E; Hein OV; Morgera S; Schink T; Ziemer S; Grund MS; Saalmann R; Kox WJ; Lehmann C
    Ren Fail; 2007; 29(3):271-7. PubMed ID: 17497439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II : adaptation of the ecarin clotting time to the act II device.
    Koster A; Loebe M; Hansen R; Bauer M; Mertzlufft F; Kuppe H; Hetzer R
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1278-83. PubMed ID: 10838548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.